You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
法國藥企Sanofi向百度李彥宏旗下公司下擲逾10億美元訂單開發AI模型
百度集團(09888.HK)(BIDU.US)創始人、董事長兼首席執行官李彥宏創立的生命科學大模型平台公司百圖生科表示,與法國製藥企業賽諾菲(Sanofi)達成合作,共同開發用於生物治療藥物發現的人工智能(AI)模型。 百圖生科獲賽諾菲1,000萬美元預付款,總交易金額超過10億美元。雙方旨在創建蛋白質大語言模型和人工智能任務模型,以實現生物製劑設計和多參數優化。 百圖生科表示,該模型使用普遍的未標記數據來為多個下游任務模型提供訊息,使包括免疫學、神經學、腫瘤學及罕見疾病在內的多個領域能夠基於有限的數據進行更精準預測。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account